For debate: Preventing atherosclerotic events with aspirin

British Medical Journal

Volumn 324, Issue 7329, 2002, Pages 103-105

  Cleland, John G F ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ANTITHROMBOCYTIC AGENT;

ATHEROSCLEROSIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; HEART DISEASE; HUMAN; KIDNEY FAILURE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; SHORT SURVEY; STROKE; SUDDEN DEATH; ARTERIOSCLEROSIS; CEREBROVASCULAR ACCIDENT; HEART INFARCTION; NOTE; SURVIVAL RATE;

ARTERIOSCLEROSIS; ASPIRIN; CEREBROVASCULAR ACCIDENT; HUMANS; META-ANALYSIS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; SURVIVAL RATE;

EID: 0037065497     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.324.7329.103     Document Type: Short Survey

References (16)

1. Prevention of death, myocardial infarction and stroke by antiplatelet therapy in high-risk patients
2. Secondary prevention of vascular disease by prolonged antiplatelet treatment
3. Collaborative overview of randomised trials of antiplatelet therapy - 1: Prevention of death, myocardial infarction, and stroke by prolonged antiplarelet therapy in various categories of patients
4. Is aspirin safe for patients with heart failure?
5. Anticoagulant and antiplatelet therapy in heart failure
6. Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors in hypertension or heart failure?
7. Persantine and aspirin in coronary heart disease
8. The aspirin myocardial infarction study: Final results
9. Persantine-aspirin reinfarction study. Part II. Secondary coronary prevention with persantine and aspirin
10. The German-Austrian aspirin trial: A comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction
11. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 eases of suspected acute myocardial infarction
12. Meeting report - LIDO, HOPE, MOXCON and WASH Studies
13. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial
14. Protective effects of aspirin against acute mycardial infarction and death in men with unstable angina
15. Peptic ulcer bleeding: Accessory risk factors and interactions with non-steroidal anti-inflammatory drugs